Abstract
Objective The late 2019 Covid-19 disease outbreak has put the health systems of many countries to the limit of their capacity. The most affected European countries are, so far, Italy and Spain. In both countries (and others), the authorities decreed a lockdown, with local specificities. The objective of this work is to evaluate the impact of the measures undertaken in Spain to deal with the pandemic.
Method We estimated the number of cases and the impact of lockdown on the reproducibility number based on the hospitalization reports up to April 15th 2020.
Results The estimated number of cases shows a sharp increase until the lockdown, followed by a slowing down and then a decrease after full quarantine was implemented. Differences in the basic reproduction ratio are also very significant, dropping from de 5.89 (95% CI: 5.46-7.09) before the lockdown to 0.48 (95% CI: 0.15-1.17) afterwards.
Conclusions Handling a pandemic like Covid-19 is very complex and requires quick decision making. The large differences found in the speed of propagation of the disease show us that being able to implement interventions at the earliest stage is crucial to minimise the impact of a potential infectious threat. Our work also stresses the importance of reliable up to date epidemiological data in order to accurately assess the impact of Public Health policies on viral outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A. H. was funded by the Spanish Ministry of Economy and Competitiveness (Ramon y Cajal fellowship RYC-2017-23231). D. M. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the Maria de Maeztu Programme for Units of Excellence in R&D (MDM-2014-0445), Instituto de Salud Carlos III (COV20/00115) and Fundacion Santander Universidades.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: A. H. was funded by the Spanish Ministry of Economy and Competitiveness (Ramón y Cajal fellowship RYC-2017-23231). D. M. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the María de Maeztu Programme for Units of Excellence in R&D (MDM-2014-0445), Instituto de Salud Carlos III (COV20/00115) and Fundación Santander Universidades.
Conflict of interest: The authors declare no conflict of interest.
Data Availability
The study used publically available data.
